First EFIC® Symposium Societal Impact of Pain - SIP
First EFIC® Symposium Societal Impact of Pain - SIP
First EFIC® Symposium Societal Impact of Pain - SIP
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Jos Kleijnen<br />
Pr<strong>of</strong>. Jos Kleijnen, MD,<br />
Director, Kleijnen Systematic Reviews Ltd, York,<br />
UK.<br />
www.systematic-reviews.com<br />
Literature review about the epidemiology <strong>of</strong><br />
chronic pain in 8 European countries and Europe<br />
as a whole.<br />
Chronic pain is very common but good data<br />
are scarce about the prevalence, incidence,<br />
diagnosis, severity, treatment, utilization <strong>of</strong><br />
health care, and the impact <strong>of</strong> chronic non-cancer<br />
pain on society, health care systems and<br />
the patient.<br />
Information about the epidemiology <strong>of</strong> chronic<br />
pain can help health care pr<strong>of</strong>essionals as well<br />
as decision and policy makers decide about<br />
health budgets and prioritization, patient segmenting<br />
and budget fencing, and therapy budgets,<br />
including behavioural therapy and drug<br />
budgets.<br />
This presentation aims to provide epidemiological<br />
information about chronic non-cancer pain<br />
in Europe using the most representative, recent,<br />
comprehensive and valid studies. We have<br />
reviewed the literature about 21 different questions<br />
relevant to chronic pain for each <strong>of</strong> the<br />
following countries: Germany, UK, France, Italy,<br />
Spain, Sweden, Denmark, the Netherlands, and<br />
Europe as a whole.<br />
The questions that we addressed ranged from<br />
what is the prevalence and incidence <strong>of</strong> chronic<br />
pain, what are the underlying diseases, what<br />
are the treatments used, what is patients’ compliance<br />
and satisfaction, to what are the costs<br />
<strong>of</strong> chronic pain? More than 1000 individual<br />
studies were included, and the results presented<br />
in reports for each country.<br />
This presentation will give some snapshots <strong>of</strong><br />
the most interesting findings: there is a tremendous<br />
amount <strong>of</strong> information about chronic pain<br />
in Europe, and the vast majority comes from<br />
the specific countries. A lot <strong>of</strong> data/studies<br />
exist, but far fewer studies addressed a representative<br />
general chronic pain population, so<br />
some care in interpretation is warranted.<br />
Prevalence <strong>of</strong> chronic pain is high in Europe<br />
(12-26%). Mean annual costs per annum per<br />
chronic pain patient are typically several<br />
thousand euros, increasing to low 5-figure<br />
sums from societal perspectives.<br />
63